Ready To Start Your Journey?
Semiglutide
What Is It?
Semaglutide is a medication simulates a natural hormone (GLP-1), encouraging the body to release more insulin following meals. It is primarily used for diabetes management can aid in weight loss by reducing appetite. As a glucagon-like peptide- (GLP-1) receptor agonist, a phase 3 clinical trial in 2021 demonstrated that weekly injections of .4 milligrams of semaglutide resulted in an average weight loss of 14.9% after 68 weeks, compared to just 2.4% with a placebo, among individuals with a body mass index (BMI) of 30 or higher.
Who Qualifies for the Weightloss Program?
-
BMI of 27 with comorbidities
-
BMI greater than 30
Contraindications for Program
-
Personal OR family history of medullary thyroid cancer
-
Patient with multiple endocrine neoplasia syndrome type 2
-
Known hypersensitivity to semiglutide
-
Pregnancy - men and women should stop using semaglutide 2 months before planning to become pregnant. Alternative medicine to control diabetes should be reviewed with a physician
-
Type 1 Diabetes diagnosis
-
History of pancreatitis
-
History of gallbladder disease
